Navigation Links
Genomma Lab Announces Updated Fourth Quarter 2008 Guidance
Date:1/13/2009

MEXICO CITY, Jan. 13 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announces that based on the main preliminary indicators obtained at the close of the fourth quarter of 2008, the Company expects to report slightly lower results than the original growth expectations. However, product sales at the point of sale continue to be in line with original projections.

Despite favorable acceptance at the point of sale, some of Genomma Lab's clients chose to marginally reduce inventory levels during the last two weeks of December, in light of the current economic situation.

During the fourth quarter, the Company maintained a strict focus on working capital, placing the Company in a very solid position in terms of liquidity.

Genomma Lab will report fourth quarter results on February 17, 2009, followed by the quarterly conference call, which will take place on the following day.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab's shares trade on the Mexican Stock Exchange under the ticker symbol "LAB".

    Web Site: www.genommalab.com

    Investor Relations Contact:
    Tel: +52 (55) 5081 0000 Ext. 4250
    E-mail: inversion@genommalab.com

    In New York:
    i-advize Corporate Communications, Inc.
    Tel: (212) 406-3691/95
    E-mail: genomma@i-advize.com

'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Genomma Lab, New Participant in Market-Maker Program
2. Genomma Lab Announces Initiation of Stock Repurchase Fund
3. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
4. Genomma Lab Announces 2009 Earnings Guidance
5. Genomma Lab Internacional Acquires UNIGASTROZOL
6. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
7. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
8. American Journal of Nursing announces 2008 Book of the Year Awards
9. AllMed Announces PeerScore Solutions for Hospital Peer Review
10. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
11. Nationwide Medical/Surgical Announces They Will Carry Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: